Inside the Clinic: Basal Cell Carcinoma Treatment Advances - Episode 8

Safety of Cemiplimab for Basal Cell Carcinoma

,

Experts review the safety and toxicity data of anti-PD-1 antibody agent cemiplimab for basal cell carcinoma treatment.

EP. 1: Overview of Basal Cell Carcinoma
EP. 2: Clinical Scenario 1: A 74-Year-Old Man with Locally Advanced Infiltrative Basal Cell Carcinoma
EP. 3: Referring Patients with Basal Cell Carcinoma to Medical Oncology
EP. 4: Treatment Options for Locally Advanced Basal Cell Carcinoma
EP. 5: Systemic Therapy Options for Basal Cell Carcinoma
EP. 6: Monitoring Strategies for Basal Cell Carcinoma
EP. 7: Clinical Scenario 2: A 66-Year-Old Woman with Locally Advanced Basal Cell Carcinoma
Now Viewing
EP. 8: Safety of Cemiplimab for Basal Cell Carcinoma
EP. 9: Metastasis Patterns of Basal Cell Carcinoma
EP. 10: Basal Cell Carcinoma Clinical Pearls

Related Content:

Inside the Clinic: Basal Cell Carcinoma Treatment AdvancesMelanoma & Skin Cancer
Dr Van Akkooi on the Prognostic Value of Minimal Sentinel Node Tumor Burden in Melanoma
Dr McKean on the Efficacy of Fianlimab Plus Cemiplimab in Advanced Melanoma
Understanding CAR T-Cell Therapy for Cancer: Mayo Clinic Expert Explains How It Works